May 23, 2009

Another Dimebon Phase III Clinical Trial

Editor Note: All Dimebon Clinical Trials into Alzheimer's disease with the exception of the Concert Study have been canceled.

If you are taking cholinesterase inhibitors and/or memantine you will not qualify for the Dimebon Connection study. However, there is another Dimebon clinical trial that has these inclusion criteria:

  • Diagnosis of Alzheimer's Disease.
  • MMSE 12-26 inclusive.
  • If on existing anti-dementia therapy, have been on a stable dose of anti-dementia therapy (cholinesterase inhibitors and/or memantine) for at least 60 days prior to dosing in study.
  • If not taking existing anti-dementia therapy, have not received therapy with cholinesterase inhibitors and/or memantine within 60 days prior to dosing in this study.
The study is currently recruiting new participants. For all the specifics including locations go here.

Subscribe to The Alzheimer's Reading Room--via Email

Popular articles on the Alzheimer's Reading Room





The Alzheimer's Action Plan: The Experts' Guide to the Best Diagnosis and Treatment for Memory Problems


Bob DeMarco is the editor of the Alzheimer's Reading Room and an Alzheimer's caregiver. The Alzheimer's Reading Room is the number one website on the Internet for news, advice, and insight into Alzheimer's disease. Bob has written more than 800 articles with more than 18,000 links on the Internet. Bob resides in Delray Beach, FL.

Original content Bob DeMarco, Alzheimer's Reading Room